Aliases & Classifications for Otitis Media

About this section

Aliases & Descriptions for Otitis Media:

Name: Otitis Media 52 11 27 50 2 39 13 68
Otitis Media, Susceptibility to 12
 
Infectious Otitis Media 68

Characteristics:

HPO:

64
otitis media:
Inheritance: familial predisposition

Classifications:



External Ids:

OMIM52 166760
Disease Ontology11 DOID:10754
ICD9CM32 382.9
MeSH39 D010033
NCIt45 C34885

Summaries for Otitis Media

About this section
Wikipedia:71 Otitis media is a group of inflammatory diseases of the middle ear. The two main types are acute otitis... more...

MalaCards based summary: Otitis Media, also known as otitis media, susceptibility to, is related to labyrinthitis and nasopharyngitis, and has symptoms including recurrent otitis media An important gene associated with Otitis Media is OMS (Otitis Media, Susceptibility To), and among its related pathways are Development and heterogeneity of the ILC family and Antifolate resistance. The drugs ceftibuten dihydrate and acetyl sulfisoxazole have been mentioned in the context of this disorder. Affiliated tissues include tonsil, bone and brain, and related mouse phenotypes are liver/biliary system and neoplasm.

Disease Ontology:11 A otitis which involves inflammation of the middle ear.

CDC:2 Español: Infección de oído

Description from OMIM:52 166760

Related Diseases for Otitis Media

About this section

Diseases related to Otitis Media via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 520)
idRelated DiseaseScoreTop Affiliating Genes
1labyrinthitis30.6CXCL8, IL10, IL1B, IL6, TNF
2nasopharyngitis30.6CD79A, CXCL8, IL1B, IL6, TNF
3primary ciliary dyskinesia30.2IL10, IL6, TNF
4tuberculosis30.2CD40LG, IL10, IL1B, IL6, TNF
5aseptic meningitis29.9TLR2, TLR4, TNF
6fasciitis29.7CXCL8, MBL2, TLR2, TNF
7myiasis29.3CD40LG, CXCL8, IL10, IL6, TLR4, TNF
8bacterial meningitis29.3ALB, CD40LG, IL6, TNF
9tracheitis29.3CCL11, CD79A, CXCL8, RNASE3, TNF
10suppurative otitis media12.6
11acute serous otitis media12.5
12non-suppurative otitis media12.5
13chronic purulent otitis media12.5
14purulent acute otitis media12.4
15chronic tubotympanic suppurative otitis media12.4
16acute allergic serous otitis media12.3
17acute sanguinous otitis media12.3
18acute allergic sanguinous otitis media12.3
19adhesive otitis media12.2
20acute allergic mucoid otitis media12.0
21chronic atticoantral disease11.9
22blue drum syndrome11.7
23mastoiditis11.5
24serous glue ear11.3
25pharyngitis11.3
26adenoid hypertrophy11.3
27eustachian tube disease11.3
28kabuki syndrome 111.1
29kabuki syndrome 211.1
30c1q deficiency10.9
31ciliary dyskinesia, primary, 2210.9
32ciliary dyskinesia, primary, 1010.9
33ciliary dyskinesia, primary, 3010.9
34ciliary dyskinesia, primary, 210.9
35deafness, progressive, with stapes fixation10.9
36middle ear cholesterol granuloma10.9
37purulent labyrinthitis10.9
38focal labyrinthitis10.9
39actinobacillosis10.9
40recombinant 8 syndrome10.9
41cholesteatoma10.6
42pneumonia10.4
43influenza10.4
44haemophilus influenzae10.4
45intussusception10.4IL1B, TNF
46thrombosis10.3
47adenoiditis10.3
48pyridoxal 5'-phosphate-dependent epilepsy10.3IL10, TNF
49myeloid proliferations related to down syndrome10.3CXCL8, TLR2
50oculomotor nerve paralysis10.3CXCL8, IL1B, IL6

Comorbidity relations with Otitis Media via Phenotypic Disease Network (PDN):


Hypertension, EssentialDeficiency Anemia
Chronic Myocardial IschemiaMastoiditis
Cholesteatoma of Middle EarHeart Disease
Acute CystitisLabyrinthitis
BronchitisOtitis Externa
Pneumococcal Meningitis

Graphical network of the top 20 diseases related to Otitis Media:



Diseases related to otitis media

Symptoms & Phenotypes for Otitis Media

About this section

Symptoms by clinical synopsis from OMIM:

166760

Clinical features from OMIM:

166760

Human phenotypes related to Otitis Media:

 64
id Description HPO Frequency HPO Source Accession
1 recurrent otitis media64 HP:0000403

MGI Mouse Phenotypes related to Otitis Media according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.0ALB, CD79A, IL10, IL6, TLR2, TLR4
2MP:00020068.8ALB, CD79A, IL10, IL1B, IL6, TLR2
3MP:00053818.5ALB, FBXO11, IL10, IL6, MUC5AC, TLR2
4MP:00053678.4ALB, CD40LG, CD79A, IL6, MBL2, TLR2
5MP:00053978.2CCL11, CD40LG, CD79A, IL10, IL1B, IL6
6MP:00053877.3CCL11, CD40LG, CD79A, FBXO11, IL10, IL1B

Drugs & Therapeutics for Otitis Media

About this section

FDA approved drugs:

id Drug Name Active Ingredient(s)16 Company Approval Date
1
Cedax16 CEFTIBUTEN DIHYDRATE Schering-Plough December 1995
FDA Label: Cedax
Disease/s that Drug Treats:chronic bronchitis, infection of the middle ear, pharyngitis/tonsillitis
Indications and Usage:16 CEDAX (ceftibuten) is indicated for the treatment of individuals with mild-to-moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below (see DOSAGE AND ADMINISTRATION and CLINICAL STUDIES sections). Acute Bacterial Exacerbations of Chronic Bronchitis due to Haemophilus influenzae (including β-lactamase-producing strains), Moraxella catarrhalis (including β-lactamaseproducing strains), or Streptococcus pneumoniae (penicillin-susceptible strains only). NOTE: In acute bacterial exacerbations of chronic bronchitis clinical trials where Moraxella catarrhalis was isolated from infected sputum at baseline, ceftibuten clinical efficacy was 22% less than control. Acute Bacterial Otitis Media due to Haemophilus influenzae (including β-lactamase-producing strains), Moraxella catarrhalis (including β-lactamase-producing strains), or Streptococcus pyogenes. NOTE: Although ceftibuten used empirically was equivalent to comparators in the treatment of clinically and/or microbiologically documented acute otitis media, the efficacy against Streptococcus pneumoniae was 23% less than control. Therefore, ceftibuten should be given empirically only when adequate antimicrobial coverage against Streptococcus pneumoniae has been previously administered. Pharyngitis and Tonsillitis due to Streptococcus pyogenes. NOTE: Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Ceftibuten is generally effective in the eradication of Streptococcus pyogenes from the oropharynx; however, data establishing the efficacy of the CEDAX product for the prophylaxis of subsequent rheumatic fever are not available.
DrugBank Targets:14 Peptidoglycan synthase FtsI|Penicillin-binding protein 1A|Penicillin-binding protein 1B|Penicillin-binding protein 2
Mechanism of Action:16 
Target: -
Action: -
FDA: -

Drugs for Otitis Media (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 231)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HalofantrineapprovedPhase 41869756-53-237393
Synonyms:
(+-)-Halofantrine hydrochloride
(1)-Halofantrine
1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6- (trifluoromethyl)-9-phenathrenemethanol
1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrene-methanol
1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride
1-(1,3-Dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol hydrochloride
1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl
106927-11-1
3-(Dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol hydrochloride
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride
36167-63-2
66051-63-6
69756-53-2
9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-(1)
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-,hydrochloride
AB00514703
AC-481
AC1L1XMK
AC1L1XMN
AC1Q4K45
BPBio1_001366
BSPBio_001241
C26H30Cl2F3NO.HCl
CHEBI:252728
CHEMBL1107
CHEMBL1200901
CID37392
CID37393
D02485
DB01218
EINECS 252-895-4
FT-0082696
 
HALOFANTRINE HYDROCHLORIDE
HMS1571O03
Halfan
Halfan (TN)
Halofantrina
Halofantrina [INN-Spanish]
Halofantrine
Halofantrine HCl
Halofantrine Hydrochloride [USAN]
Halofantrine [USAN]
Halofantrine [Usan]
Halofantrine hydrochloride (USAN)
Halofantrino
Halofantrino [Spanish]
Halofantrinum
Halofantrinum [INN-Latin]
I14-2822
LS-102675
LS-187198
MLS002154111
MolPort-005-940-418
MolPort-005-942-171
NCGC00179250-01
NCI60_002593
Prestwick0_001031
Prestwick1_001031
Prestwick2_001031
Prestwick3_001031
SK&F-102866
SMR001233418
SPBio_003092
UNII-H77DL0Y630
UNII-Q2OS4303HZ
WR 171,699
WR 171669
WR-171,669
WR-171669
WR-171699
dl-WR 171669
2
MontelukastapprovedPhase 4, Phase 3270158966-92-85281040
Synonyms:
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
CHEBI:50730
CHEMBL787
CID5281040
 
D08229
DB00471
HMS2089D07
HSDB 7582
LS-173539
MK 0476
MK-0476
Montair
Montelukast
Montelukast (INN)
Montelukast [INN:BAN]
Montelukastum
Montélukast
Singulair
Singular
UNII-MHM278SD3E
montelukast
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
3
Amoxicillinapproved, vet_approvedPhase 4, Phase 3, Phase 246526787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
4
OseltamivirapprovedPhase 4, Phase 3104204255-11-8, 196618-13-065028
Synonyms:
(-)-oseltamivir
(3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid
(−)-oseltamivir
196618-13-0
204255-11-8
4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
AC1L22FK
AC1Q63H0
Agucort
Agucort (TN)
BIDD:GT0426
BRD-K76011241-045-01-5
C08092
CHEBI:7798
CHEMBL1229
CID65028
D08306
DB00198
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate
FT-0082384
 
GS 4104
GS-4104
GS4104
HMS2090C11
HSDB 7433
LS-57422
MolPort-005-933-026
NCGC00178698-01
Oseltamivir
Oseltamivir (INN)
Oseltamivir [INN:BAN]
Oseltamivir phosphate
Oseltamivirum
Ro-64-0796
Ro-640796
Tamiflu (*Phosphate salt 1:1*)
Tamiflu-Free
Tamvir
UNII-20O93L6F9H
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
oseltamivir
oseltamivirum
oséltamivir
5
CefdinirapprovedPhase 4, Phase 2, Phase 32591832-40-56915944
Synonyms:
(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-7-(2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
91832-40-5
AC1OCD3C
BIDD:GT0827
BMY 28488
BSPBio_002735
C08110
C14H13N5O5S2
CFDN
CHEBI:3485
CHEMBL927
CI 983
CI-983
CID6915944
Cefdinir
Cefdinir (JP15/USAN/INN)
Cefdinir [USAN:INN]
Cefdinirum
 
Cefdinirum [INN-Latin]
Cefdinyl
Cefdirnir
Cefzon
Cefzon (TN)
D00917
DB00535
FK 482
FK-482
FR-80482
HMS1922L19
HMS2093K20
KS-1038
LS-149988
MolPort-002-885-812
NCGC00178499-01
Omnicef
Omnicef (TN)
Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir
PD 134393
PD-134393
S1605_Selleck
SPECTRUM1505208
Spectrum5_001560
UNII-CI0FAO63WC
cefdinir
6
Dexamethasoneapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 1, Phase 2217150-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
 
Dexameth
Dexamethansone
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
7
Morphineapproved, investigationalPhase 4100757-27-25288826
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(-)-Morphine
(-)Morphine sulfate
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(−)-morphine
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
47106-99-0
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
8053-16-5
85201-37-2
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
CID5288826
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
DepoDur
Depodur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
HSDB 2134
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
 
Infumorph
Kadian
LS-91748
M-Eslon
M.O.S
MOI
MORPHINE SULFATE
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
MS Contin
MS/L
MS/S
MSIR
Meconium
MolPort-003-849-273
Morfina
Morfina [Italian]
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine Sulfate
Morphine [BAN]
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
Ms Emma
NSC11441
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
RMS
RMS Uniserts
Rescudose
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
UNII-76I7G6D29C
Unkie
l-Morphine
morfina
morphine
nchembio.317-comp1
nchembio.64-comp1
8
Fentanylapproved, illicit, investigational, vet_approvedPhase 4, Phase 2, Phase 3821437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
9
Ciprofloxacinapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 123685721-33-12764
Synonyms:
1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
17850_FLUKA
3-Quinolinecarboxylic acid,1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)
33434_FLUKA
33434_RIEDEL
85721-33-1
AC-7613
AC1L1EEW
AKOS000269653
ARONIS020379
Alcon Cilox
BAS 06989041
BAY q 3939
BAY-Q-3939
BAYQ3939
BIDD:GT0205
BPBio1_000140
BRD-K04804440-311-02-3
BRN 3568352
BSPBio_000126
BSPBio_003344
Bacquinor
Baflox
Bay o 9867
Bay o 9867 (*Hydrochloride*)
Bay-09867
Baycip
Bernoflox
Bi-Cipro
Bio-0540
C05349
C17H18FN3O3
CAS-93107-08-5
CBMicro_048498
CCRIS 5241
CHEBI:100241
CHEMBL8
CID2764
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
CPF
CPFX
CRL-1605 & Ciprofloxacin
Ciflox
Cifloxin
Cilab
Ciloxan
Ciloxan (*Hydrochloride*)
Ciplus
Ciprecu
Ciprinol
Cipro
Cipro (*Hydrochloride*)
Cipro (TN)
Cipro I.V.
Cipro IV
Cipro XL
Cipro XR
Ciprobay
Ciprobay Uro
Ciprocinol
Ciprodar
Ciproflox
Ciprofloxacin (JAN/USP/INN)
Ciprofloxacin HCl
Ciprofloxacin Hydrchloride
Ciprofloxacin [USAN:INN:BAN]
Ciprofloxacin dihydrochloride
Ciprofloxacin hydrochloride
Ciprofloxacin monohydrochloride
Ciprofloxacina
Ciprofloxacine
Ciprofloxacine [INN-French]
Ciprofloxacino
Ciprofloxacino [INN-Spanish]
Ciprofloxacinum
 
Ciprofloxacinum [INN-Latin]
Ciprogis
Ciprolin
Ciprolon
Cipromycin
Ciproquinol
Ciprowin
Ciproxan
Ciproxin
Ciproxina
Ciproxine
Ciriax
Citopcin
Cixan
Corsacin
Cycin
Cyprobay
D00186
DB00537
DivK1c_000095
Eni
Fimoflox
Flociprin
Floxin
HMS1922E18
HMS2090O07
HMS2093I03
HMS500E17
HSDB 6987
IDI1_000095
Ipiflox
Italnik
KBio1_000095
KBio2_000642
KBio2_003210
KBio2_005778
KBio3_002846
KBioGR_001567
KBioSS_000642
LS-141563
Liposomal-ciprofloxacin
Loxan
MLS001336035
MolPort-000-819-654
NCGC00016959-01
NCGC00095058-01
NCGC00095058-02
NCGC00178128-01
NINDS_000095
NSC620634
Ocuflox
Oprea1_008239
Oprea1_313572
Prestwick0_000113
Prestwick1_000113
Prestwick2_000113
Prestwick3_000113
Probiox
Proflaxin
Proflox
Proksi 250
Proksi 500
Proquin XR
Quinolid
Quintor
Rancif
Roxytal
SMP1_000125
SMR000471901
SPBio_001474
SPBio_002065
SPECTRUM1503614
STK021082
Septicide
Sophixin Ofteno
Spectrum2_001567
Spectrum3_001872
Spectrum4_000874
Spectrum5_001089
Spectrum_000162
Spitacin
Superocin
UNII-5E8K9I0O4U
Unex
Velomonit
Zumaflox
ciprofloxacin
nchembio820-comp1
10
Lansoprazoleapproved, investigationalPhase 4218103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Compraz
D00355
DB00448
Dakar
DivK1c_000920
EU-0100709
FT-0082011
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lanston
 
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
11
AzithromycinapprovedPhase 4, Phase 3, Phase 234683905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
12
KetorolacapprovedPhase 432374103-06-3, 66635-83-43826
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
(+-)-isomer
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC-545
AC1L1GSW
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
 
I14-2832
Ketoralac
Ketorolac
Ketorolac (INN)
Ketorolac Tromethamine
Ketorolac [INN:BAN]
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
Kétorolac
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
RS 37619
RS-37619
SBB067312
STL018674
Toradol (TN)
UNII-YZI5105V0L
ketorolac
rac-Ketorolac
13
Acetylcysteineapproved, investigationalPhase 4330616-91-112035
Synonyms:
(2R)-2-acetylamino-3-sulfanylpropanoic acid
(R)-2-acetylamino-3-mercaptopropanoic acid
(R)-mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
Fluprowit
 
L-Acetylcysteine
L-acetylcysteine
L-α-acetamido-β-mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetyl-L-(+)-cysteine
N-acetyl-L-cysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
14AnalgesicsPhase 4, Phase 2, Phase 311733
15beta-Lactamase InhibitorsPhase 4, Phase 3, Phase 1, Phase 2294
16Clavulanic AcidPhase 4, Phase 3, Phase 2170
17Analgesics, Non-NarcoticPhase 4, Phase 2, Phase 36501
18Amoxicillin-Potassium Clavulanate CombinationPhase 4, Phase 3, Phase 2137
19AnestheticsPhase 4, Phase 2, Phase 39596
20Central Nervous System DepressantsPhase 4, Phase 2, Phase 313403
21Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
22Anesthetics, GeneralPhase 4, Phase 2, Phase 32934
23Anti-Asthmatic AgentsPhase 43488
24Hormone AntagonistsPhase 4, Phase 3, Phase 1, Phase 213180
25Respiratory System AgentsPhase 44997
26VaccinesPhase 4, Phase 3, Phase 1, Phase 26611
27Leukotriene AntagonistsPhase 4293
28Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 1, Phase 213168
29Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 123689
30Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 1, Phase 2465
31Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 111226
32Protective AgentsPhase 4, Phase 37443
33Aluminum phosphatePhase 4, Phase 1, Phase 235
34HormonesPhase 4, Phase 3, Phase 1, Phase 214415
35AntioxidantsPhase 4, Phase 33050
36AntidotesPhase 4, Phase 31071
37Pharmaceutical SolutionsPhase 4, Phase 3, Phase 28192
38AntiemeticsPhase 4, Phase 3, Phase 1, Phase 24022
39Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 1, Phase 25592
40HIV Protease InhibitorsPhase 4, Phase 3, Phase 1, Phase 25470
41Dexamethasone acetatePhase 4, Phase 3, Phase 1, Phase 221711177-87-3
42
protease inhibitorsPhase 4, Phase 3, Phase 1, Phase 25471
Synonyms:
 
protease inhibitors
43Topoisomerase InhibitorsPhase 4, Phase 3, Phase 2, Phase 15069
44Dexamethasone 21-phosphatePhase 4, Phase 3, Phase 1, Phase 22171
45Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 2, Phase 13917
46BB 1101Phase 4, Phase 3, Phase 1, Phase 22171
47Cytochrome P-450 CYP1A2 InhibitorsPhase 4, Phase 3, Phase 2, Phase 1572
48Autonomic AgentsPhase 4, Phase 3, Phase 1, Phase 210150
49glucocorticoidsPhase 4, Phase 3, Phase 1, Phase 25103
50Gastrointestinal AgentsPhase 4, Phase 3, Phase 1, Phase 28402

Interventional clinical trials:

(show top 50)    (show all 246)
idNameStatusNCT IDPhase
1Amoxicillin Clavulanate in Treatment of Acute Otitis MediaUnknown statusNCT00299455Phase 4
2The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in ChildrenUnknown statusNCT00393159Phase 4
3Pneumococcal Vaccines Early and in CombinationUnknown statusNCT01174849Phase 4
4Acute Otitis Media (AOM) Therapy Trial in Young ChildrenCompletedNCT00377260Phase 4
5A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in ChildrenCompletedNCT00189462Phase 4
6Long-term Antibiotics for Treatment and Prevention of Otitis Media in Aborignal ChildrenCompletedNCT00539149Phase 4
7Effect of Prevnar 13 on Ear Infections in ChildrenCompletedNCT01199016Phase 4
8Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaCompletedNCT00195611Phase 4
9A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis MediaCompletedNCT00645112Phase 4
10A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis MediaCompletedNCT00644943Phase 4
11Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in ChildrenCompletedNCT01082029Phase 4
12Postoperative Effects of Intranasal Fentanyl, IV and IM Morphine in Children Undergoing MyringotomyCompletedNCT01244126Phase 4
13Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)CompletedNCT00419380Phase 4
14Early Oseltamivir Treatment of Influenza in Children 1-3 Years of AgeCompletedNCT00593502Phase 4
15DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic EffectCompletedNCT00424905Phase 4
16Hutterite Influenza Prevention StudyCompletedNCT00877396Phase 4
17Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.CompletedNCT01694108Phase 4
18Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in ChildrenRecruitingNCT02935374Phase 4
19Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in ChildrenRecruitingNCT02653742Phase 4
20Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)RecruitingNCT01800747Phase 4
21Live Versus Inactivated Influenza Vaccine Study in Hutterite ChildrenActive, not recruitingNCT01653015Phase 4
22Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of LifeEnrolling by invitationNCT01735084Phase 4
23N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis MediaNot yet recruitingNCT00956748Phase 4
24TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)Not yet recruitingNCT03096327Phase 4
25A Comparative Study of the Outcomes of 2 Surgical Procedures for Safe Type of Chronic Otitis MediaUnknown statusNCT00271778Phase 3
26A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis MediaUnknown statusNCT00270660Phase 3
27PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear DiseaseUnknown statusNCT00310349Phase 3
28Preventing Early Childhood Caries in Indigenous Children: the Baby Teeth Talk StudyUnknown statusNCT02151916Phase 3
29Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean ChildrenUnknown statusNCT01619462Phase 3
30Improving Otitis Media Care With Clinical Decision SupportCompletedNCT00581711Phase 3
31Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone ChildrenCompletedNCT01044030Phase 3
32Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in ChildrenCompletedNCT00781521Phase 3
33A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00578474Phase 3
34Sinuclean Nebules 45 for Treatment of Pediatric Exudative Otitis MediaCompletedNCT02858388Phase 3
35Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy TubesCompletedNCT02600559Phase 3
36Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis MediaCompletedNCT00638534Phase 3
37Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine SerotypesCompletedNCT00378417Phase 3
38Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis MediaCompletedNCT00051753Phase 3
39Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00579189Phase 3
40Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in ChildrenCompletedNCT02541760Phase 3
41Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial FloraCompletedNCT01027494Phase 3
42Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis MediaCompletedNCT00645203Phase 2, Phase 3
43Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)CompletedNCT02432105Phase 3
44Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2CompletedNCT02436304Phase 3
45Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis MediaCompletedNCT02044341Phase 3
46Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily TympanometryCompletedNCT01244581Phase 3
47Acute Otitis Media: Adjuvant Therapy to Improve OutcomeCompletedNCT00000363Phase 3
48Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric PatientsCompletedNCT01404611Phase 3
49Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis MediaCompletedNCT00360100Phase 3
50Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid SpraysCompletedNCT00279916Phase 3

Search NIH Clinical Center for Otitis Media

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: otitis media

Genetic Tests for Otitis Media

About this section

Genetic tests related to Otitis Media:

id Genetic test Affiliating Genes
1 Otitis Media27

Anatomical Context for Otitis Media

About this section

MalaCards organs/tissues related to Otitis Media:

36
Tonsil, Bone, Brain, Neutrophil, Testes, T cells, Colon

Publications for Otitis Media

About this section

Articles related to Otitis Media:

(show top 50)    (show all 1552)
idTitleAuthorsYear
1
Acute Otitis Media in Children. (28084706)
2017
2
Meteorological factors, air pollutants, and emergency department visits for otitis media: a time series study. (28466414)
2017
3
Antibiotics in Pregnancy Increase Children's Risk of Otitis Media and Ventilation Tubes. (28088397)
2017
4
Comparison of first year of life acute otitis media admissions before and after the 13-valent pneumococcal conjugate vaccine. (28483246)
2017
5
Indicators for continuous quality improvement for otitis media in primary health care for Aboriginal and Torres Strait Islander children. (28088980)
2017
6
Polymorphisms of Mannose-binding Lectin and Toll-like Receptors 2, 3, 4, 7 and 8 and the Risk of Respiratory Infections and Acute Otitis Media in Children. (28403045)
2017
7
Microbiology of otitis media in Indigenous Australian children: review. (28088924)
2017
8
Recurrent acute otitis media detracts from health-related quality of life. (28073387)
2017
9
The Predictive Value of Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio for the Effusion Viscosity in Otitis Media With Chronic Effusion. (28468206)
2017
10
Otitis Media with Effusion: Our National Practice. (28535139)
2017
11
Radiological Imaging of Rare Intracranial Complications Secondary to Otitis Media and Mastoiditis. (28468135)
2017
12
Authors' reply: changes in gustatory function in patients with chronic otitis media before and after tympanoplasty. (28477052)
2017
13
Recurrent otorrhea in chronic suppurative otitis media: is biofilm the missing link? (28466356)
2017
14
The human otitis media with effusion: a numerical-based study. (28460599)
2017
15
Iatrogenic trichloroacetic acid injury causing necrotizing otitis media and deafness. (28483224)
2017
16
Clinical practice guidelines for the diagnosis and management of otitis media with effusion (OME) in children in Japan, 2015. (28473270)
2017
17
Determinants of chronic otitis media with effusion in preschool children: a case-control study. (28056905)
2017
18
Curcumin Inhibits NTHi-Induced MUC5AC Mucin Overproduction in Otitis Media via Upregulation of MAPK Phosphatase MKP-1. (28487811)
2017
19
Intranasal Steroid Use for Otitis Media with Effusion: Ongoing Opportunities for Quality Improvement. (28535109)
2017
20
Healthcare-seeking behaviour of primary caregivers for acute otitis media in children aged 6A months to <30A months in Panama: results of a cross-sectional survey. (28056896)
2017
21
Can Serum Neutrophil-to-Lymphocyte Ratio Be a Predictive Biomarker to Help Differentiate Active Chronic Otitis Media From Inactive Chronic Otitis Media? (28468213)
2017
22
Otitis media in children: A proposal for a new nosological classification. (28011068)
2017
23
Tympanostomy Tube Placement vs Medical Management for Recurrent Acute Otitis Media in TRICARE-Insured Children. (28535362)
2017
24
No evidence for impaired humoral immunity to pneumococcal proteins in Australian Aboriginal children with otitis media. (28012512)
2017
25
Infectious complications of pediatric cochlear implants are highly influenced by otitis media. (28483256)
2017
26
Higher Serum 25(OH)D Concentration is Associated with Lower Risk of Chronic Otitis Media with Effusion: A Case-Control Study. (28477429)
2017
27
Otiprio: An FDA-Approved Ciprofloxacin Suspension Gel for Pediatric Otitis Media With Effusion. (28479839)
2017
28
Values Range of Tympanometric Gradient in Otitis Media With Effusion. (28468223)
2017
29
Response to Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland. (28064237)
2017
30
Duration of antibiotics for acute otitis media in under 2 year olds. (28470812)
2017
31
Sensorineural hearing loss in patients with chronic suppurative otitis media: Is there a significant correlation? (28465813)
2017
32
Volumetric Changes in the Bony External Auditory Canal in Unilateral Chronic Otitis Media. (27144233)
2016
33
Suppurative labyrinthitis associated with otitis media: 26 years' experience. (26718959)
2016
34
Chronic Suppurative Otitis Media Complicated With Mastoiditis: An Unusual Presentation of Tuberculosis. (27865308)
2016
35
General practice antibiotic prescribing for management of otitis media in children. (27622222)
2016
36
Evaluation of Role of Mastoid Surgery in the Management of Safe Chronic Suppurative Otitis Media. (27833868)
2016
37
Differentiating Acute Otitis Media and Acute Mastoiditis in Hospitalized Children. (27613655)
2016
38
Evidence and evidence gaps in the treatment of Eustachian tube dysfunction and otitis media. (28025605)
2016
39
Acute Otitis Media - The Long and the Short of It. (28002710)
2016
40
Surveillance of bacteria Pseudomonas aeruginosa and MRSA associated with chronic suppurative otitis media. (27177975)
2016
41
Sensorineural hearing loss after otitis media with effusion and subacute mastoiditis after viral infections of the upper respiratory tract: A comparative study of conservative and surgical treatment. (27657322)
2016
42
Treatment of otitis media by transtympanic delivery of antibiotics. (27629487)
2016
43
Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage. (27997514)
2016
44
Nystagmus in patients with unilateral acute otitis media complicated by serous labyrinthitis. (26797398)
2016
45
Cochlear implantation in deaf patients with eosinophilic otitis media using subtotal petrosectomy and mastoid obliteration. (27168402)
2016
46
Antibiotic Treatment for First Episode of Acute Otitis Media Is Not Associated with Future Recurrences. (27632355)
2016
47
Iatrogenic facial nerve injuries during chronic otitis media surgery: a multicenter retrospective study. (27661064)
2016
48
Evaluation of the Interleukin-1 Receptor Antagonist and Immunoregulatory Interleukin-10 in the Middle Ear in Chronic Otitis Media With Effusion in Children With and Without Atopy. (27090281)
2016
49
Ten Year Study of Acute Otitis Media in Rochester, NY. (27182898)
2016
50
Molecular Microbiological Profile of Chronic Suppurative Otitis Media. (27487953)
2016

Variations for Otitis Media

About this section

Expression for genes affiliated with Otitis Media

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Otitis Media patients vs. healthy controls: 35
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1PNLIPRP3pancreatic lipase-related protein 3Blood-6.470.003
2FAM20Afamily with sequence similarity 20, member ABlood+3.090.015

Search GEO for disease gene expression data for Otitis Media.

Pathways for genes affiliated with Otitis Media

About this section

Pathways related to Otitis Media according to GeneCards Suite gene sharing:

(show top 50)    (show all 54)
idSuper pathwaysScoreTop Affiliating Genes
19.6IL1B, IL6, TNF
29.6IL1B, IL6, TNF
39.6IL1B, IL6, TNF
4
Show member pathways
9.6CD40LG, CXCL8, TNF
59.6IL10, IL1B, TNF
69.5CXCL8, IL6, TNF
79.5IL1B, TLR2, TLR4, TNF
8
Show member pathways
9.4IL1B, IL6, TLR2, TLR4
99.4IL6, TLR2, TLR4, TNF
109.3CXCL8, IL1B, IL6, TNF
11
Show member pathways
9.3CXCL8, IL1B, IL6, TLR4
129.2CD79A, IL10, IL6, TNF
139.2IL10, IL1B, IL6, TNF
149.2IL10, IL1B, IL6, TNF
159.2IL10, IL1B, IL6, TNF
16
Show member pathways
9.2CD40LG, IL1B, TLR2, TLR4, TNF
17
Show member pathways
9.2ALB, IL1B, IL6, TNF
189.1CD40LG, CXCL8, IL1B, TLR4, TNF
19
Show member pathways
9.0CXCL8, IL6, TLR2, TLR4, TNF
209.0CXCL8, IL1B, IL6, TLR4, TNF
21
Show member pathways
9.0CXCL8, IL1B, IL6, TLR4, TNF
22
Show member pathways
9.0CD40LG, CXCL8, IL1B, IL6, TNF
238.9IL10, IL1B, IL6, TLR4, TNF
24
Show member pathways
8.9CD40LG, IL10, IL1B, IL6, TNF
25
Show member pathways
8.9CXCL8, IL10, IL1B, IL6, TNF
268.9CXCL8, IL10, IL1B, IL6, TNF
278.9CXCL8, IL10, IL1B, IL6, TNF
288.9CD40LG, CD79A, IL10, IL1B, TLR2, TNF
29
Show member pathways
8.8CD40LG, IL1B, IL6, TLR2, TLR4, TNF
30
Show member pathways
8.8CXCL8, IL1B, IL6, TLR2, TLR4, TNF
318.8CXCL8, IL1B, IL6, TLR2, TLR4, TNF
328.8CXCL8, IL1B, IL6, TLR2, TLR4, TNF
33
Show member pathways
8.8CD40LG, IL10, IL1B, TLR2, TLR4, TNF
348.7IL10, IL1B, IL6, TLR2, TLR4, TNF
35
Show member pathways
8.7IL10, IL1B, IL6, TLR2, TLR4, TNF
36
Show member pathways
8.7IL10, IL1B, IL6, TLR2, TLR4, TNF
378.7CCL11, CXCL8, IL1B, IL6, MUC5B, TNF
388.6CD40LG, IL10, IL6, TLR2, TLR4, TNF
398.6CCL11, CD40LG, IGHE, IL10
408.6CXCL8, IL10, IL1B, IL6, TLR4, TNF
41
Show member pathways
8.5CD40LG, CD79A, IGHE, IL10, TNF
42
Show member pathways
8.4CCL11, CXCL8, IL1B, IL6, TLR2, TLR4
438.4CXCL8, IL10, IL1B, IL6, TLR2, TLR4
44
Show member pathways
8.2CCL11, CD40LG, CXCL8, IL10, IL1B, IL6
458.2CCL11, CD40LG, CXCL8, IL10, IL1B, IL6
46
Show member pathways
8.2CXCL8, IL10, IL1B, IL6, MBL2, TLR2
478.1CD40LG, CXCL8, IL10, IL1B, IL6, TLR2
48
Show member pathways
8.0CCL11, CD40LG, CXCL8, IL10, IL1B, IL6
49
Show member pathways
7.9CXCL8, IL1B, IL6, MUC5AC, MUC5B, TLR2
50
Show member pathways
7.8CCL11, CXCL8, IL1B, IL6, MUC5AC, MUC5B

GO Terms for genes affiliated with Otitis Media

About this section

Cellular components related to Otitis Media according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mucus layerGO:00707019.6MUC5AC, MUC5B
2external side of plasma membraneGO:00098979.0CD40LG, CD79A, IGHE, IL6, TLR4, TNF
3extracellular spaceGO:00056156.1A2ML1, ALB, CCL11, CD40LG, CXCL8, IL10
4extracellular regionGO:00055766.1A2ML1, ALB, CCL11, CD40LG, CXCL8, IGHE

Biological processes related to Otitis Media according to GeneCards Suite gene sharing:

(show all 47)
idNameGO IDScoreTop Affiliating Genes
1cellular response to lipoteichoic acidGO:007122310.8TLR2, TLR4
2positive regulation of calcidiol 1-monooxygenase activityGO:006055910.7IL1B, TNF
3positive regulation of chemokine biosynthetic processGO:004508010.7IL1B, TNF
4positive regulation of fever generationGO:003162210.7IL1B, TNF
5positive regulation of interleukin-8 biosynthetic processGO:004541610.6TLR4, TNF
6epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.6IL6, TNF
7regulation of establishment of endothelial barrierGO:190314010.6IL1B, TNF
8negative regulation of lipid storageGO:001088810.6IL6, TNF
9endothelial cell apoptotic processGO:007257710.6IL10, TNF
10regulation of immunoglobulin secretionGO:005102310.6CD40LG, TNF
11negative regulation of cytokine secretion involved in immune responseGO:000274010.5IL10, TNF
12positive regulation of MHC class II biosynthetic processGO:004534810.5IL10, TLR4
13receptor biosynthetic processGO:003280010.4IL10, TNF
14positive regulation of phagocytosisGO:005076610.4IL1B, MBL2, TNF
15positive regulation of interferon-gamma productionGO:003272910.4IL1B, TLR4, TNF
16positive regulation of JNK cascadeGO:004633010.4IL1B, TLR4, TNF
17positive regulation of interleukin-10 productionGO:003273310.4CD40LG, TLR2, TLR4
18positive regulation of interleukin-12 productionGO:003273510.4CD40LG, TLR2, TLR4
19B cell differentiationGO:003018310.3CD40LG, CD79A, IL10
20B cell proliferationGO:004210010.3CD40LG, CD79A, IL10
21negative regulation of growth of symbiont in hostGO:004413010.3IL10, MBL2, TNF
22neutrophil chemotaxisGO:003059310.3CCL11, CXCL8, IL1B
23positive regulation of heterotypic cell-cell adhesionGO:003411610.3IL10, IL1B, TNF
24negative regulation of interleukin-6 productionGO:003271510.3IL10, TLR4, TNF
25lipopolysaccharide-mediated signaling pathwayGO:003166310.2IL1B, TLR2, TLR4, TNF
26cellular response to interleukin-1GO:007134710.2CCL11, CXCL8, IL6
27positive regulation of T cell proliferationGO:004210210.2CD40LG, IL1B, IL6
28positive regulation of interleukin-8 productionGO:003275710.2IL1B, TLR2, TLR4, TNF
29positive regulation of NF-kappaB import into nucleusGO:004234610.2IL1B, TLR2, TLR4, TNF
30positive regulation of chemokine productionGO:003272210.1IL6, TLR2, TLR4, TNF
31response to insulinGO:003286810.1IL10, IL6, TLR2
32response to glucocorticoidGO:005138410.1IL10, IL6, TNF
33positive regulation of nitric oxide biosynthetic processGO:004542910.0IL1B, IL6, TLR4, TNF
34sequestering of triglycerideGO:003073010.0IL1B, TNF
35defense response to Gram-positive bacteriumGO:005083010.0IL6, MBL2, RNASE3, TLR2, TNF
36positive regulation of ERK1 and ERK2 cascadeGO:00703749.9CCL11, IL6, TLR4, TNF
37positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.8IL10, IL1B, IL6, TNF
38positive regulation of gene expressionGO:00106289.8IL1B, IL6, TLR2, TLR4, TNF
39positive regulation of interleukin-6 productionGO:00327559.8IL1B, IL6, TLR2, TLR4, TNF
40negative regulation of cell proliferationGO:00082859.7CXCL8, IL10, IL1B, IL6, TLR2
41cellular response to lipopolysaccharideGO:00712229.6CXCL8, IL10, IL6, TLR4, TNF
42response to molecule of bacterial originGO:00022379.6CXCL8, IL10, TLR2
43positive regulation of NF-kappaB transcription factor activityGO:00510929.5CD40LG, IL1B, IL6, TLR2, TLR4, TNF
44response to lipopolysaccharideGO:00324969.3IL10, IL1B, IL6, TLR2, TLR4
45defense response to bacteriumGO:00427428.8IGHE, IL10, MBL2, MUC5B, RNASE3, TLR4
46inflammatory responseGO:00069548.5CCL11, CD40LG, CXCL8, IL10, IL1B, IL6
47immune responseGO:00069557.7CCL11, CD40LG, CXCL8, IGHE, IL10, IL1B

Molecular functions related to Otitis Media according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lipopolysaccharide receptor activityGO:000187510.0TLR2, TLR4
2cytokine activityGO:00051258.3CCL11, CD40LG, CXCL8, IL10, IL1B, IL6

Sources for Otitis Media

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet